Aripazine (PER977) reverses unfractionated and low molecular weight heparins, fondaparinux and new oral anticoagulants: report of a clinical trial with edoxaban and anticoagulant reversal biomarker identification.
PHARMACOTHERAPY(2014)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要